Shenzhen YHLO Biotech (SHA:688575) obtained medical device registrations from Guangdong's regulator for its sST2 chemiluminescence assay kit and the iMegaFlow chemiluminescence immunoassay analyzer.
The sST2 kit supports the diagnosis of acute myocardial infarction and heart failure, while the iMegaFlow analyzer enables the detection of analytes, according to a Wednesday filing with the Shanghai bourse.